Electra Therapeutics, Inc. IPO
listed
| Exchange | Nasdaq |
| Ticker | ETRA |
| Price range | $14–16 |
| IPO price | $15 |
| Deal size | $350m |
| First-day close | $13.25 (-11.7%) |
| Priced | 17 Sep 2026 |
| First trading day | 18 Sep 2026 |
| First filing seen | 14 Sep 2026 |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | South San Francisco, CA |
| Incorporated in | DE |
Antibody biotech priced an upsized 23.33M-share IPO at $15, the midpoint of its $14-$16 range, raising $350.0M (over-allotment treatment not stated). First-day close $13.25 per IPOScoop.
SEC filings
| Form | What it is | Filed |
|---|---|---|
| S-1/A | Amended registration statement | 14 Sep 2026 |
Deal terms: IPOScoop ↗ · Filings: SEC EDGAR ↗
This page reports public filings and reported deal terms. It is not a recommendation to buy, sell or apply.